$1.62 (0.38%)
Industry, Sector & symbol
| Stock Exchange | NYSE |
| CEO | Gail Koziara Boudreaux |
| Industry | Medical - Healthcare Plans |
| Sector | Healthcare |
| Current Symbol | ELV |
| CUSIP | 036752103 |
| CIK | 0001156039 |
| Web | https://www.elevancehealth.com |
| Phone | 800 331 1476 |
| Currency | USD |
| Employees | 97100 |
| Country | US |
Liquidity
| Debt-to-Equity Ratio | 0.73 |
| Payout Ratio | 0.29 |
| Current Ratio | 1.48 |
| Quick Ratio | 1.48 |
| Cash Ratio | 0.21 |
Sales & Book Value
| Annual Sales | $199.12B |
| Price / Sales | 0.46 |
| Cash Flow | 29.25 |
| Price / Cash Flow | 14.37 |
| Price / Book | 2.14 |
Price Target and Rating
| Average Stock Price Forecast | $444.50 |
| High Stock Price Forecast | $498.00 |
| Low Stock Price Forecast | $331.00 |
| Forecast Upside/Downside | -3.98% |
| Consensus Rating | Buy |
| Rating Score(0-5) | 4 |
| Research Coverage | 38 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $25.12 |
| Trailing P/E Ratio | 18.15 |
| PEG Ratio | -2.09 |
| P/E Growth | -2.09 |
| Net Income | $5.66B |
| Net Margin | 2.62% |
| Pretax Margin | 3.10% |
| Return on Equity | 11.95% |
| Return on Assets | 4.17% |
Financials Score
| AltmanZ Score | 3.08 |
| Piotroski Score | 7.00 |
| Working Capital | 21.72B |
| Total Assets | 125.83B |
| Ebit | 7.63B |
| Market Cap | 92.36B |
| Total Liabilities | 81.78B |
About Elevance Health Inc. (NYSE:ELV) Stock
Operating as a major health benefits organization, Elevance Health Inc. commits to guiding consumers, families, and communities across their entire health and wellness path. It facilitates access to vital care, assistance, and tools designed to enable healthier living for approximately 118 million individuals. The company's comprehensive offerings span medical, digital, pharmaceutical, behavioral health, clinical, and other care solutions. Founded in 1944 and based in Indianapolis, Indiana, this entity adopted its current name, Elevance Health Inc., in June 2022, having previously operated as Anthem, Inc. ...
Will Health Benefits Weakness Drag Elevance's Q2 Earnings?
2026-07-13 15:11:07
ELV faces Q2 pressure as weaker Health Benefits results and higher benefit expenses may weigh on earnings ahead of its July 15 report.
Eyes On Elevance Health, UnitedHealth For Continued Insurer Rebound
2026-07-13 07:05:12
This week's Elevance Health and UnitedHealth Group quarterly earnings are much anticipated for signs these companies' health insurance businesses and that of their rivals are keeping a handle on rising costs.
Elevance and UnitedHealth Earnings Are Next Test for Hot Health Insurer Stocks
2026-07-13 03:00:00
Elevance reports results July 15, followed by UnitedHealth July 16, and CVS Health on Aug. 5.
Elevance Health: Defense For An Undervalued Price
2026-07-11 08:45:00
Elevance Health has outperformed the benchmark, rising 28% versus 11%, and I see further upside potential. ELV demonstrates steady top- and bottom-line growth, supporting a premium multiple and reinforcing management confidence. The insurance market's steady growth is a structural tailwind; if ELV maintains market share, it stands to benefit.
Is ELV's Capital Allocation Strategy Creating Long-Term Value?
2026-07-10 13:25:23
Elevance Health's disciplined capital allocation, strong cash generation and continued investments in Carelon and AI support long-term growth while rewarding shareholders.
Curious about Elevance Health (ELV) Q2 Performance? Explore Wall Street Estimates for Key Metrics
2026-07-10 10:16:09
Beyond analysts' top-and-bottom-line estimates for Elevance Health (ELV), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2026.
3 Cheap Medical Stocks to Buy as US-Iran Tensions Keep Markets on Edge
2026-07-09 15:26:04
U.S.-Iran tensions likely to lift demand for defensive plays, with Tenet Healthcare, Elevance Health and Aveanna Healthcare standing out as cheap medical stocks.
Analysts Estimate Elevance Health (ELV) to Report a Decline in Earnings: What to Look Out for
2026-07-08 11:01:10
Elevance Health (ELV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Frequently Asked Questions
What is the current Elevance Health Inc. (ELV) stock price?
Elevance Health Inc.(NYSE:ELV) stock price is $426.79 in the last trading session. During the trading session, ELV stock reached the peak price of $436.24 while $273.71 was the lowest point it dropped to. The percentage change in ELV stock occurred in the recent session was 0.38% while the dollar amount for the price change in ELV stock was $1.62.
ELV's industry and sector of operation?
The NYSE listed ELV is part of Medical - Healthcare Plans industry that operates in the broader Healthcare sector.
Who are the executives of ELV?
Charles Morgan Kendrick Jr.
| EVP and President of Commercial & Specialty Health Benefits
Mark Bradley Kaye
| Executive Vice President & Chief Financial Officer
Nathan Allen Rich
| Vice President of Investor Relations
Peter David Haytaian
| Special Advisor
Ronald William Penczek
| Senior Vice President, Controller & Chief Accounting Officer
How many employees does ELV have?
Number of ELV employees currently stands at 97100. ELV operates from 220 Virginia Avenue, Indianapolis, IN 46204, US.
Link for ELV official website?
Official Website of ELV is: https://www.elevancehealth.com
How do I contact ELV?
ELV could be contacted at phone #800 331 1476 and can also be accessed through its website. ELV operates from 220 Virginia Avenue, Indianapolis, IN 46204, US.
How many shares of ELV are traded daily?
The average number of ELV shares traded daily for last 3 months was 1.72M.
What is the market cap of ELV currently?
The market value of ELV currently stands at $92.68B with its latest stock price at $426.79